Mirtazapine for fibromyalgia in adults
Información
- DOI:
- https://doi.org/10.1002/14651858.CD012708Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 29 junio 2017see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Dolor y cuidados paliativos
- Copyright:
-
- Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
WH, SD, and RAM drafted the protocol. All authors had input into the protocol development and agreed the final version.
Sources of support
Internal sources
-
Oxford Pain Relief Trust, UK.
General institutional support
External sources
-
National Institute for Health Research (NIHR), UK.
NIHR Cochrane Programme Grant: 13/89/29 ‐ Addressing the unmet need of chronic pain: providing the evidence for treatments of pain
Declarations of interest
PW: none known. PW is a specialist pain physician and manages patients with fibromyalgia.
KB: none known; KB is a clinical psychologist and manages patients with fibromyalgia. She is member of the committee of the German guideline on fibromyalgia.
SD: none known.
RAM has received grant support from Grünenthal relating to individual patient level analyses of trial data regarding tapentadol in osteoarthritis and back pain (2015). He has received honoraria for attending boards with Menarini concerning methods of analgesic trial design (2014), with Novartis (2014) about the design of network meta‐analyses, and RB on understanding pharmacokinetics of drug uptake (2015). He has received honoraria from Omega Pharma (2016) and Futura Pharma (2016) for providing advice on trial and data analysis methods.
WH is a specialist in general internal medicine, psychosomatic medicine and pain medicine, who treats patients with fibromyalgia. He is a member of the medical board of the German Fibromyalgia Association. He is the head of the steering committee of the German guideline on fibromyalgia and a member of the steering committee of the European League Against Rheumatism (EULAR) update recommendations on the management of fibromyalgia. He received speaking fees for one educational lecture from Grünenthal (2015) on pain management.
Acknowledgements
Institutional support is provided by the Oxford Pain Relief Trust.
The National Institute for Health Research (NIHR) is the largest single funder of Cochrane Pain, Palliative and Supportive Care (PaPaS). Disclaimer: the views and opinions expressed herein are those of the review authors and do not necessarily reflect those of the NIHR, National Health Service (NHS) or the Department of Health.
This protocol is based on a template developed in collaboration with Cochrane Neuromuscular Diseases and Cochrane Musculoskeletal. The editorial process is managed by PaPaS.
Version history
| Published | Title | Stage | Authors | Version |
| 2018 Aug 06 | Mirtazapine for fibromyalgia in adults | Review | Patrick Welsch, Kathrin Bernardy, Sheena Derry, R Andrew Moore, Winfried Häuser | |
| 2017 Jun 29 | Mirtazapine for fibromyalgia in adults | Protocol | Patrick Welsch, Kathrin Bernardy, Sheena Derry, R Andrew Moore, Winfried Häuser | |
Keywords
MeSH
Medical Subject Headings (MeSH) Keywords
Medical Subject Headings Check Words
Adult; Humans;
